Clinipace Inc., doing business as Caidya, is a leading global clinical research organization specializing in rare diseases and orphan drugs. With a focus on accelerating the development of innovative therapies for underserved patient populations, Caidya offers comprehensive clinical trial services, regulatory support, and strategic consulting. Their team of experts is dedicated to navigating the unique challenges of orphan drug development, providing tailored solutions to optimize study design, patient recruitment, and regulatory compliance. Caidya's commitment to advancing rare disease research makes them a valuable partner for pharmaceutical companies, biotechs, and academic institutions seeking to bring life-changing treatments to market efficiently and ethically.